Cargando…
PIAS1 protects against myocardial ischemia-reperfusion injury by stimulating PPARγ SUMOylation
BACKGROUND: Myocardial ischemia-reperfusion injury (IRI) has become one of the most serious complications after reperfusion therapy in patients with acute myocardial infarction. Small ubiquitin-like modification (SUMOylation) is a reversible process, including SUMO E1-, E2-, and E3-mediated SUMOylat...
Autores principales: | Xie, Bo, Liu, Xinyu, Yang, Jie, Cheng, Jinke, Gu, Jianmin, Xue, Song |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6233564/ https://www.ncbi.nlm.nih.gov/pubmed/30419807 http://dx.doi.org/10.1186/s12860-018-0176-x |
Ejemplares similares
-
PIAS1 Alleviates Hepatic Ischemia-Reperfusion Injury in Mice through a Mechanism Involving NFATc1 SUMOylation
por: Luo, Jing, et al.
Publicado: (2022) -
Protective role of the deSUMOylating enzyme SENP3 in myocardial ischemia-reperfusion injury
por: Rawlings, Nadiia, et al.
Publicado: (2019) -
Rosuvastatin relieves myocardial ischemia/reperfusion injury by upregulating PPAR-γ and UCP2
por: Wang, Ling, et al.
Publicado: (2018) -
Nitric Oxide Destabilizes Pias3 and Regulates Sumoylation
por: Qu, Jing, et al.
Publicado: (2007) -
PIAS3 modulate HIV-1 integrase SUMOylation
por: Beauclair, Guillaume, et al.
Publicado: (2011)